Natalie Revelle leads the Volume Guarantee initiative and structured financing investments within the Strategic Investment Fund (SIF) team. Working with pharmaceutical companies, sovereign and private foundation partners, donors, and implementing partners, Natalie has structured a portfolio of investments across global health commodities including vaccines, family planning, and HIV products that is expected to generate over $1 billion of procurement savings to the global health industry.
Prior to the joining the foundation, Natalie held a number of strategy and financial advisory roles. Most recently, Natalie worked at McKinsey & Company where she served high tech clients on strategy development, procurement, and pricing topics.
Natalie is a graduate of Harvard Business School and Princeton University with a Bachelor of Arts in Economics.